NMC

NEA Management Company Portfolio holdings

AUM $1.33B
This Quarter Return
-12.31%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$1.52B
AUM Growth
+$1.52B
Cap. Flow
-$90.4M
Cap. Flow %
-5.96%
Top 10 Hldgs %
80.05%
Holding
36
New
2
Increased
1
Reduced
3
Closed
1

Top Buys

1
CSBR icon
Champions Oncology
CSBR
$8.36M
2
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$835K
3
AKTX
Akari Therapeutics
AKTX
$645K

Top Sells

1
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
$43.5M
2
VTAE
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
$37.6M
3
GYRE icon
Gyre Therapeutics
GYRE
$18.2M
4
PRTK
Paratek Pharmaceuticals, Inc.
PRTK
$929K

Sector Composition

1 Healthcare 72.83%
2 Communication Services 10.44%
3 Technology 8.46%
4 Consumer Discretionary 1.1%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AUPH icon
26
Aurinia Pharmaceuticals
AUPH
$1.58B
$7.23M 0.48% 2,546,843 – –
DZSI
27
DELISTED
DZS Inc. Common Stock
DZSI
$6.55M 0.43% 4,781,290 – –
ROKA
28
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$6.28M 0.41% 3,220,433 – –
ECOM
29
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$5.53M 0.36% 556,692 – –
ARQL
30
DELISTED
Arqule Inc
ARQL
$4.71M 0.31% 2,520,316 – –
VIRX
31
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$4.61M 0.3% 5,689,644 +1,030,311 +22% +$835K
GYRE icon
32
Gyre Therapeutics
GYRE
$703M
$3.04M 0.2% 652,380 -3,914,286 -86% -$18.2M
PRTK
33
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$2.38M 0.16% 125,004 -48,888 -28% -$929K
AGRX
34
DELISTED
Agile Therapeutics, Inc
AGRX
$900K 0.06% 133,488 – –
AKTX
35
Akari Therapeutics
AKTX
$24.8M
$645K 0.04% +26,894 New +$645K
VTAE
36
DELISTED
VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE
– – -2,613,199 Closed -$37.6M
1
2